No. The number crunching boneheads don't distinguish between DRUG trials and STEM cells.
It is delusional to assert that the outcome of stage 3 is a NO. If it were, the FDA would never agree to it.
Stop pretending it's all logical outcomes. Teva has overreacted on the basis of their obviously poor decisionmaking on DRUG trials, and they've compounded this bad decisionmaking with a worse call.
Quite frankly, I'm glad they did as we now have the IP clear of them. (Sweating on this a bit aren't you?)
Celgene, page-18
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.57 |
Change
0.000(0.00%) |
Mkt cap ! $1.764B | |||
| Open | High | Low | Value | Volume |
| $1.56 | $1.57 | $1.52 | $1.514M | 981.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 20014 | $1.56 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.57 | 25138 | 10 |
View Market Depth
| Last trade - 11.31am 18/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |